A long waiting time from diagnosis to treatment decreases the survival of non-small cell lung cancer patients with stage IA1: A retrospective study
ObjectiveThe prognostic effect of delayed treatment on stage IA1 non-small cell lung cancer (NSCLC) patients is still unclear. This study aimed to explore the association between the waiting time before treatment and the prognosis in stage IA1 NSCLC patients.MethodsEligible patients diagnosed with p...
Main Authors: | Bin Liu, Jia-Yi Qian, Lei-Lei Wu, Jun-Quan Zeng, Shu-Quan Xu, Jin-Hua Yuan, Yong-Liang Zheng, Dong Xie, Xiaolu Chen, Hai-Hong Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Surgery |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fsurg.2022.987075/full |
Similar Items
-
A gene-based score for the risk stratification of stage IA lung adenocarcinoma
by: Yanlu Xiong, et al.
Published: (2024-01-01) -
Significant difference in recurrence according to the proportion of high grade patterns in stage IA lung adenocarcinoma
by: Hyun Woo Jeon, et al.
Published: (2021-07-01) -
Survival analysis and clinicopathological features of patients with stage IA lung adenocarcinoma
by: Jiahao Li, et al.
Published: (2024-01-01) -
Tumor Differentiation and EGFR Mutation Associated with Disease-Free Survival in Stage IA Lung Adenocarcinoma Patients with Curative Surgery
by: Yang L, et al.
Published: (2020-12-01) -
Clinical significance of epidermal growth factor receptor mutations in resected stage IA non-small cell lung cancer
by: Yuan-Ming Tsai, et al.
Published: (2022-01-01)